Resources
ARG in Top 15: 2018 Inc. 5000 By the Numbers
Atlantic Research Group, with 3-year growth of 118%, recently appeared on The 2018 Inc. 5000 list of the fastest-growing private companies […]
August 23, 2018
LPLV 2 Months Ahead of Schedule
ARG CEO Paul Bishop just received the following feedback from a Global Pharmaceutical Sponsor: ARG is a rare disease-focused contract […]
July 17, 2018
Pivotal Phase III trial undergoes audits by the FDA and sponsor
Challenge: A pivotal Phase III clinical trial of C1 inhibitor for the prophylactic treatment of hereditary angioedema managed by ARG […]
June 1, 2018
Does Your CRO Innovate To Keep Trials On Track?
ARG knows from experience that the willingness to be flexible has fueled our success in rare disease clinical trials, resulting in approvals with over $3B in sales.
May 9, 2018
ARG successfully starts up a Phase II trial within 6 weeks
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and […]
May 1, 2018
Is Your CRO a Genuine Operational Partner?
ARG's history of successfully operationalizing rare disease clinical research has been driven by comprehensive engagement with our sponsors.
April 6, 2018